ONPH
Price:
$0.004
Market Cap:
$109.55K
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.
Industry
Biotechnology
IPO Date
1994-10-31
Stock Exchange
OTC
Ticker
ONPH
According to Oncology Pharma Inc.’s latest financial reports and current stock price. The company's current ROE is -19427.83%. This represents a change of 16.09% compared to the average of -120.03% of the last 4 quarters.
The mean historical ROE of Oncology Pharma Inc. over the last ten years is 5.47%. The current -19427.83% ROE has changed -455.16% with respect to the historical average. Over the past ten years (40 quarters), ONPH's ROE was at its highest in in the March 2004 quarter at 135.47%. The ROE was at its lowest in in the December 2003 quarter at -52800.00%.
Average
5.47%
Median
141.42%
Minimum
-8389.65%
Maximum
57.33%
Discovering the peaks and valleys of Oncology Pharma Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 17.49%
Maximum Annual ROE = 57.33%
Minimum Annual Increase = -630.07%
Minimum Annual ROE = -8389.65%
| Year | ROE | Change |
|---|---|---|
| 2022 | -8389.65% | -114.63% |
| 2021 | 57.33% | 17.49% |
| 2020 | 326.02% | -18.49% |
| 2019 | 399.96% | -56.04% |
| 2004 | 909.88% | -621.99% |
| 2003 | -174.31% | 111.93% |
| 2002 | -82.25% | 90.46% |
| 2001 | -43.19% | -51.97% |
| 2000 | -89.92% | -101.99% |
| 1998 | 4.51% | -630.07% |
The current ROE of Oncology Pharma Inc. (ONPH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
16.42%
5-year avg
10.12%
10-year avg
5.47%
Oncology Pharma Inc.’s ROE is less than Panacos Pharmaceuticals, Inc. (-85.57%), greater than Better Therapeutics, Inc. (-221.99%), greater than TetraLogic Pharmaceuticals Corporation (-408.63%), less than Arno Therapeutics, Inc. (250.44%), less than Ampio Pharmaceuticals, Inc. (-113.96%), less than Calithera Biosciences, Inc. (-131.13%), greater than Wuhan General Group (China), Inc. (-316.07%), less than Innovation1 Biotech Inc. (2.07%), less than Baudax Bio, Inc. (1.07%), less than InnerScope Hearing Technologies, Inc. (13.06%),
| Company | ROE | Market cap |
|---|---|---|
| -85.57% | $5.37K | |
| -221.99% | $5.45K | |
| -408.63% | $2.45K | |
| 250.44% | $4.93K | |
| -113.96% | $5.90K | |
| -131.13% | $975.00 | |
| -316.07% | $11.03K | |
| 2.07% | $4.49K | |
| 1.07% | $436.00 | |
| 13.06% | $3.61K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncology Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oncology Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Oncology Pharma Inc.'s ROE?
How is the ROE calculated for Oncology Pharma Inc. (ONPH)?
What is the highest ROE for Oncology Pharma Inc. (ONPH)?
What is the 3-year average ROE for Oncology Pharma Inc. (ONPH)?
What is the 5-year average ROE for Oncology Pharma Inc. (ONPH)?
How does the current ROE for Oncology Pharma Inc. (ONPH) compare to its historical average?